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The global burden of stroke continues to grow. Although stroke prevention strategies (e.g.,
medications, diet, and exercise) can contribute to risk reduction, options for acute interven-
tions (e.g., thrombolytic therapy for ischemic stroke) are limited to the minority of patients.
The remaining patients are often left with profound neurological disabilities that substan-
tially impact quality of life, economic productivity, and increase caregiver burden. In the last
decade, however, the future outlook for such patients has been tempered by movement
toward the view that the brain is capable of reorganizing after injury. Many now view brain
recovery after stroke as an area of scientific research with large potential for therapeutic
advances, far into the future (Broderick and William, 2004). As a probe of brain anatomy,
function and physiology, magnetic resonance imaging (MRI) is a non-invasive and highly
versatile modality that promises to play a particularly important role in such research. Here
we provide a basic review of MRI physical principles and applications for assessing stroke,
looking toward the future role MRI may play in improving stroke rehabilitation methods and
stroke recovery.
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INTRODUCTION
Diagnostic imaging is an invaluable aspect of clinical stroke med-
icine, providing the location, volume, and the nature of the stroke
lesion. Anatomical imaging of stroke patients historically has been
done with computed tomography (CT), but ever-increasingly is
supplanted by the superb soft tissue contrast provided by magnetic
resonance imaging (MRI). The versatility of MRI methods also
enables much more detailed biophysical information on stroke
physiology, above and beyond lesion structure. For example, just
after stroke onset, diffusion-weighted MRI (DWI), and perfusion-
weighted MRI (PWI) provide information about diffusion of
water molecules and microvascular blood flow within brain tis-
sue, respectively. The DWI and PWI methods help to evaluate
the ischemic zone surrounding infarcted tissue that is poten-
tially salvageable by recanalization therapies. Magnetic resonance
angiography (MRA) approaches are also available to character-
ize larger-scale vasculature. In the post-acute and chronic phases,
functional MRI (fMRI) offers the ability to detect alterations in
brain activation patterns post stroke, either associated with a par-
ticular behavioral task or during the resting state. It is also possible
now to image cerebral blood flow completely non-invasively using
arterial spin labeling (ASL) MRI. In this review, we provide bio-
physical understanding of these and other basic MRI methods,
and discuss their application to stroke recovery.
BASIC PHYSICAL PRINCIPLES
Use of MRI in medicine has evolved from the discovery of nuclear
magnetic resonance (NMR) in the 1950s (Bloch, 1946; Purcell
et al.,1946). The term NMR is apt –nuclear refers to specific atomic
nuclei which, when placed in a large applied static magnetic field,
can undergo resonance (substantial energy absorption and subse-
quent energy emission if a pulsed magnetic wave is applied at a
certain characteristic frequency). For NMR to occur, the nuclei of
interest must have the quantum mechanical property of non-zero
“spin.” Such nuclei simplistically can be thought of as very small
objects with spinning charge, and therefore exhibiting nuclear
magnetic fields. When placed in a large applied magnetic field,
the nuclear magnetic fields tend to align with the applied field.
The simplest scenario involves the hydrogen nucleus, or proton,
which can take on two different energy states: a low-energy “spin-
up” state in which the nuclear magnetic field partially aligns to the
external field, and a higher-energy “spin-down” state in which the
nuclear field aligns partially anti-parallel. The word“partial” refers
to the fact that in each state, the alignment is not perfect. Rather,
the nuclear field “precesses” around the direction of external field.
A good analogy for this effect is a spinning top, the axis of which
begins to wobble (precess) about the direction of gravity as the top
“winds down.” In the case of NMR, the frequency of precession
is known as the Larmor frequency. The Larmor frequency is the
resonance frequency of the system, and transitions between energy
states are possible if a magnetic pulse is applied at the Larmor fre-
quency. Typically, a pulse in the radiofrequency (RF) portion of
the electromagnetic spectrum is required for NMR, similar to the
frequencies used in FM radio.
The NMR effect is one remarkable example of how quan-
tum mechanical effects occurring over extremely small distances
(approximately 10−10 m) can manifest as macroscopic, observable
signals. Within a material containing NMR-capable nuclei, the
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nuclear magnetic fields for the given energy states can be thought
of as “adding up,” resulting in a net nuclear magnetization. The
material is very slightly magnetized when placed in a large static
magnetic field, due to the population imbalance in favor of pro-
tons in the more favorable low-energy state. The magnetization is
typically small at room temperature because thermal energy is suf-
ficient to promote a small change between the spin energy states.
If the external magnetic field is made strong enough, the nuclear
magnetization increases to the point that a signal can be easily
observed above the noise background of a detector circuit. For
this reason, current MRI systems operate using superconductor
technology to generate very large static magnetic fields of 1.5–3.0
Tesla, with ultra-high field systems at 7.0 Tesla and beyond under
development (1 Tesla is approximately 2× 104 times the Earth’s
magnetic field).
The conventional manner for observing nuclear magnetization
involves three steps. First, the sample is placed in a large applied
magnetic field, creating magnetization in the parallel or “longi-
tudinal” direction. Second, a magnetic RF pulse is applied at the
Larmor frequency, causing energy absorption that perturbs the
energy states and consequently the magnetization. The RF pulse
has the macroscopic effect of “tipping” the magnetization out of
alignment with the applied field, leading to a vector component
oriented transverse (orthogonal) to the longitudinal direction and
that oscillates at the Larmor frequency. Lastly, the oscillating trans-
verse magnetization component is detected as an NMR signal
using a “receiver coil.” In its simplest form, a receiver coil consists
of an appropriately oriented loop of wire that records an NMR-
related oscillating voltage induced by the transverse magnetization,
according to Faraday’s Law of Induction.
Early in the development of NMR, it was recognized that hydro-
gen exhibits the largest nuclear magnetic field and thus the largest
NMR signal of all the elements. This is fortuitous, given that hydro-
gen in water is by far the most biologically abundant of nuclei. An
additional strength is the remarkable versatility of NMR, to probe
not only the magnetic field properties of the nucleus, but also mol-
ecular interactions. Collectively, these effects provide an unrivaled
mechanism to probe the soft tissues of the body in a non-invasive
manner.
MAIN SOURCES OF NMR SIGNAL CONTRAST
In the early 1970s, it became increasingly apparent that biological
tissues often exhibit markedly different NMR signal characteris-
tics (Damadian, 1971). There are several ways to obtain tissue
contrast, i.e., the ability to detect different tissue types based on
the associated NMR signal differences. First, the number of pro-
tons per unit volume, or proton density, is a factor that weights
all NMR signals. Typically the proton density of tissues is rather
uniform throughout the body and a moderate source of signal
contrast. Much improved signal contrast is obtained based on sev-
eral NMR parameters that characterize how magnetization tends
to recover toward its equilibrium condition after the RF pulse is
turned off. The RF pulse tips magnetization out of alignment with
the external magnetic field, typically producing vector compo-
nents in the longitudinal direction and in the transverse direction.
Magnetization then immediately starts to return to its equilibrium
condition, resulting in recovery of longitudinal magnetization,and
decay of transverse magnetization. In simple fluids such as water,
both processes are exponential in nature. Recovery of longitudinal
magnetization is characterized by the time constant T1, whereas
decay of transverse magnetization is characterized by the time con-
stant T2. In tissues, typical T1 values range from approximately
300–2000 ms at 1.5 and 3.0 Tesla, respectively, with a tendency
for T1 to increase as the applied magnetic field increases. The
analogous values for T2 range from approximately 30–300 ms.
Table 1 provides proton density, T1, and T2 values for different
brain tissues.
Table 1 indicates that T1 and T2 values differ by approximately
a factor of 10, and vary for different tissues. The reason for tissue-
related differences in relaxation times is multifaceted (Bronskill
and Graham, 1993), but several of the key issues can be briefly
summarized. Considering T1 relaxation first, the recovery of lon-
gitudinal magnetization is primarily influenced by re-population
of spin states. When an RF pulse causes increased population of the
spin-down state, the subsequent probability of spontaneous decays
to the low-energy spin-up state is very low. Transitions occur pre-
dominantly due to “stimulated emission,” an effect that requires
a source of magnetic field fluctuations primarily at the Larmor
frequency. The source of these fluctuations is dynamic proton-
proton magnetic field interactions from within water molecules
and between neighboring water molecules as they tumble and
translate. This relaxation process is influenced by factors such as
temperature, viscosity, and the presence of ions, macromolecules,
and tissue microstructures such as cell membranes. The effect is
additionally complicated by the fact that water molecules typically
can diffuse through multiple different relaxation environments
within tissues during the T1 timescale. The process of T2 relax-
ation is additionally influenced by the magnetic fields associated
with very slow components of molecular motion, as these perturb
the Larmor frequency for individual protons and reduce the coher-
ence of nuclear magnetic fields in the transverse plane. This effect
explains why T2 is much shorter than T1 in tissues, and why pro-
tons from large macromolecules are typically not observed during
MRI. In the latter case, these protons have very slow rates of mol-
ecular motion and the resulting magnetic field non-uniformity at
the nuclear scale leads to T2 values of approximately 10µs, too
small for observation with conventional MRI technology.
Table 1 | List of relaxation times by tissue type and main magnetic
field svtrength (Gati et al., 1997; Kruger et al., 2001; Lu et al., 2005;Wu
and Wong, 2006).
Field
strength (T)
Tissue T1 (ms) T2 (ms) T2* (ms) Proton
density
1.5 White matter 510 67 78 0.61
Gray matter 760 77 69 0.69
Arterial blood 1441 290 55 0.72
CSF 2650 280 n.a. 1.0
3.0 White matter 1080 70 50 0.61
Gray matter 1820 100 50 0.69
Arterial blood 1932 275 46 0.72
CSF 3817 1442 n.a. 1.0
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Table 1 also includes one other NMR parameter, known as
T2∗. Both T2 and T2∗ parameters reflect decay of transverse
magnetization, as measured using different NMR experiments.
T2 is measured using a technique known as “spin-echo refo-
cusing” (Carr and Purcell, 1954) that measures the decay of
transverse magnetization while compensating for all macroscopic
sources of magnetic field inhomogeneity in space (e.g., spatial
variation in the applied magnetic field). The T2∗ parameter is
measured in the absence of such compensation, and is typi-
cally smaller than the T2 value. The relatively fast T2∗ decay
is due primarily to the fact that biological tissues are highly
heterogeneous with the constitutive components often support-
ing slightly different applied magnetic fields at the microscopic
level. These differences arise from spatial variations in mag-
netic susceptibility, a property of all materials. The result is
that tissue will exhibit a range of different Larmor frequencies
even if the external main magnetic field is perfectly uniform,
reducing the coherence of signal oscillation in the transverse
plane and causing more rapid decay of transverse magnetiza-
tion than is measured by the T2 parameter. Thus, T2∗ provides
an additional mechanism to achieve tissue-specific NMR signal
contrast.
DEVELOPMENT OF MRI
Early investigations of NMR signals from tissues focused partic-
ularly on the ability to detect cancer and distinguish malignant
from benign lesions, and provided some of the impetus for devel-
oping methods to encode NMR signals spatially in the form of
images. Key innovators in these subsequent developments were
Lauterbur and Mansfield, who received the Nobel Prize in phys-
iology and medicine in 2003. Over the years, the term “nuclear”
has been dropped to avoid any potential misconception that the
imaging methodology involves use of ionizing radiation – hence
the modern acronym MRI. The first whole-body MRI systems
were developed for commercial use in the late 1980s, and since
then there has been a steady increase in technical capabilities.
Today, multifaceted MRI “protocols” are achieved with approx-
imately 1 mm spatial resolution and exquisite image contrast.
Specialized sequences of RF pulses are used to provide images
weighted by different MRI signal parameters in examination times
of approximately 30 min.
The key technological concept that led to the development of
MRI is the “imaging gradient” for spatial encoding. The imag-
ing gradient is an electrical circuit that produces a linear change in
magnetic field as a function of position. MRI systems provide mag-
netic field gradients in the three orthogonal directions x, y, and z.
Importantly, although the gradient directions are orthogonal, the
orientation of the magnetic field from each gradient is always in
the direction of the large external magnetic field. Consequently,
a given gradient produces a linear variation in Larmor frequency
with position and can be used to encode NMR signals in the gradi-
ent direction (Lauterbur, 1973). In comparison with the external
magnetic field, gradient fields are much smaller, on the order of
10 milliTesla/meter. They are also designed to be pulsed on and
off throughout the imaging procedure, enabling spatial encoding
in the x, y, and z directions. It is the pulsing of imaging gradi-
ents (leading to vibrational forces within the magnet bore) that
is responsible for the characteristic buzzing, knocking, or pinging
sounds that occur during MRI scans.
Both “multi-slice” and three-dimensional (3D) MRI require
multiple repetitions of RF pulse excitation, data acquisition, and
recovery periods to obtain all the necessary spatial encoding infor-
mation required for image reconstruction. Typically, 3D MRI is
advantageous over 2D MRI because isotropic spatial resolution is
possible and the data can be straightforwardly reformatted post-
acquisition into different image plane orientations (e.g., axial,
sagittal, coronal, arbitrary oblique). However, 2D MRI is typically
more time-efficient and is widely used on this basis. Clinically,
both types of imaging have scan times that usually fall within the 1–
10 min range. There is also a class of “fast” MRI techniques capable
of providing a fully encoded image slice in approximately 100 ms,
or multi-slice datasets in approximately 1–2 s. The most common
of these techniques is echo planar imaging (EPI) (Stehling et al.,
1991), capable of full spatial encoding within a single RF excita-
tion followed by data acquisition during rapidly varying gradient
waveforms. EPI can be used to image time-dependent physiolog-
ical processes that occur on the timescale of seconds, such as the
wash-in of injectable contrast agents. However, fast imaging has
costs: reduced signal-to-noise ratio (SNR), reduced spatial resolu-
tion,and regions of signal loss and substantial geometric distortion
arising from sensitivity to magnetic field uniformity.
MRI OF CEREBROVASCULAR RISK FACTORS
Magnetic resonance imaging is being used increasingly as part of
the cerebrovascular work-up to assess risk of stroke. Vascular risk
factors like hypertension, type 2 diabetes mellitus, and the natural
course of aging are associated with an increase in the prevalence of
subclinical brain lesions (Thompson and Hakim, 2009). For exam-
ple, individuals with type 2 diabetes that have brain lesions on MRI
appear to have a two to fivefold increase in stroke occurrence com-
pared to non-diabetics (Baird et al., 2002). Cerebrovascular risk
factors can manifest as white matter disease (see Figures 1E,F),
lacunes, small vessel disease, and/or Virchov Robin spaces, which
may be considered subclinical if they do not produce an overt neu-
rological symptom. These features may be viewed as an“incidental
finding”but it is more apt to refer to these events as“covert strokes.”
For example, meta-analyses show that white matter lesions are a
significant risk factor for stroke, dementia, and death (Biernaskie
et al., 2004). Thus, as we advance our understanding of the stroke
in the acute and chronic stages it is imperative to characterize
the underlying cerebrovascular pathologies that may have con-
tributed to the stroke in the first place, and that will also influence
the potential for recovery.
MRI OF ACUTE STROKE
An MRI protocol is a set of individual image acquisitions that
each have different signal contrast weightings, assembled with the
goal of detecting pathology in a comprehensive manner. Such
protocols are becoming increasingly critical in an acute stroke
setting, to direct stroke interventions and characterize recov-
ery (Leiva-Salinas et al., 2011). For example, it is possible to
design an MRI protocol that identifies regions of possible active
ischemia, hemorrhage, and occluded vessels, and that provides
insight regarding the size and location of the core infarct as well as
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FIGURE 1 | Multiple MRI pulse sequences can be used to assess
cerebrovascular risks. The magnitude (A) and phase (B) images in phase
contrast angiography can be used to calculate cerebral blood flow velocity in
arteries (red arrows) and veins. (C) Susceptibility-weighted images (SWI)
provide high spatial resolution (<1 mm in plane resolution) of venous
anatomy. The inset shows medullary draining veins (blue arrows). (D–F)
Patient 1 provides structural images, T1 (D), FLAIR (E), and T2-weighted (F),
with the latter two images showing subcortical white matter disease (yellow
arrow). (G) a normal perfusion-weighted image obtained by
contrast-enhanced dynamic susceptibility contrast.
the extent of surrounding tissue that potentially can be salvaged
(the ischemic penumbra). A typical acute stroke MRI protocol
consists of diffusion-weighted imaging (DWI), fluid attenuated
inversion recovery (FLAIR), MRA, perfusion-weighted imaging
(PWI), and T2-weighted imaging. Some representative examples
of these techniques are shown in Figures 1 and 2, as they are sen-
sitive both to overt and covert stroke, with further detail to follow
below.
Standard MRI sequences that provide T1-weighting or T2-
weighting, and their derivatives, are well known to be insensitive
to the immediate effects of cerebral ischemia. By contrast, DWI
is highly sensitive to ischemia (Mascalchi et al., 2005). The tech-
nique is based on the use of a pair of counter-balanced, pulsed
imaging gradients applied in the same direction. The first gradient
pulse is used to encode protons as a function of position, whereas
the second is used to remove this encoding. If protons are com-
pletely static, the counter-balanced gradient pulses have no effect
and the resultant MRI signal is proportional to the net magneti-
zation within a voxel. However, if the protons move between the
application of the gradient pulses, as is the case for water mole-
cules diffusing in biological tissue, then the spatial encoding is not
fully removed and is measured as a signal attenuation providing
diffusion-weighted contrast. If the degree of diffusion weighting is
manipulated in a series of DWI experiments, simple mathematical
modeling enables calculation of an apparent diffusion coefficient
(ADC) image, which has information distinct from that provided
by proton density or relaxation time parameters.
Within minutes of vessel occlusion, failure of the sodium-
potassium pump and associated cytotoxic edema leads to an influx
of water from the extracellular space to the intracellular space. This
impedes the diffusion of water molecules, as cell membranes act
as more of a barrier. The restricted diffusion of water molecules
results in increased signal intensity on DWI. The use of DWI is
approximately four to five times more sensitive for detecting acute
stroke than is non-contrast CT (Chalela et al., 2007).
The combined use of FLAIR and DWI helps to distinguish acute
from sub-acute and chronic stroke lesions. The FLAIR technique
(De Coene et al., 1992) is a variant of the historic “inversion recov-
ery” NMR experiment, in which an RF pulse is used to invert net
magnetization. During the ensuing T1 recovery, the inverted lon-
gitudinal magnetization initially shrinks in magnitude, vanishes,
and then grows toward its equilibrium value once again. For FLAIR
imaging, and timing parameters are adjusted so that the MRI sig-
nal is acquired when cerebrospinal fluid is T1-nulled. Given that
CSF tends to pool within the infarct zone as time progresses, use
of FLAIR combined with DWI can improve the identification of
new lesions near sites of prior ischemic injury, potentially provid-
ing insight into stroke physiology and subtype. At present there
is some debate on whether the FLAIR on its own can be used to
predict the time from symptom onset. Typically, FLAIR imaging
can detect the presence of ischemia approximately 3 h after stroke
(Thomalla et al., 2009). Recent work suggests that using FLAIR rel-
ative signal intensity ratios from ischemic to contralateral regions
of interest may be better than visual inspection alone for predicting
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FIGURE 2 | Patient 2 is an acute stroke with mild impairment
(NIHSS=1) yet the diffusion-weighted image (DWI) (A) shows
restricted diffusion in the left frontal lobe (red arrow) and a large
vessel obstruction on the× (TOF) angiography (B). (C,D) Arterial spin
labeling images show reduced cerebral blood flow (CBF) and prolonged
arterial transit time (ATT) (shaded in dark red) (Based on MacIntosh et al.,
2010). Patient 3 shows the right parietal lobe stroke lesion on T1 (E) and
T2-weighted (F) images.
the time of symptom onset. This approach has good sensitivity but
poor specificity (Cheng et al., 2013). Time of symptom onset is of
critical importance given that the only clinically approved ther-
apy for acute stroke at present, recombinant tissue plasminogen
activator (rt-PA), requires administration within several hours of
stroke onset (Taussky et al., 2011). Therefore, maximizing the use
of rt-PA places an increasing need on the availability and capability
of MRI for assessing acute stroke.
Magnetic resonance angiography provides a non-invasive
method to screen for vessel occlusions, stenosis, or malformations.
There are two MRI techniques available for this purpose, with
each performing slightly less sensitively than the gold standard,
digital subtraction angiography. Three-dimensional time-of-flight
angiography (3DTOF) (Davis et al., 1993) provides a non-invasive
method of assessing the intracranial circulation. The technique is
based on the fact that if RF pulses are applied rapidly in succession,
there is little time for T1 recovery of longitudinal magnetiza-
tion. Over time, a steady-state of longitudinal magnetization is
obtained that is lower than the equilibrium magnetization. How-
ever, if blood flows into the imaging plane it still retains its
equilibrium value and thus exhibits positive image contrast with
respect to the background static tissues. This effect enables imag-
ing of the vascular lumen, but only for through-plane flow. An
alternative to 3DTOF is contrast-enhanced magnetic resonance
angiography (CE-MRA) (Runge et al., 1993), typically involving
the intravenous injection of a paramagnetic contrast agent such
as Gadolinium Diethyl-Triamine-Penta-Acetic acid (Gd-DTPA).
This agent enhances T1 relaxation, increasing the signal intensity
of blood on appropriately T1-weighted images, with respect to
the signal from static tissues. This technique provides more con-
trast than 3DTOF and is much less sensitive to flow dynamics.
Consequently, CE-MRA can be used more effectively to image
extracranial and intracranial vessels. If scan time permits, the two
angiographic methods are complementary and use of both 3DTOF
and CE-MRA can improve diagnostic ability (Sohn et al., 2003).
Evidence is also accumulating that CE-MRA can be used to scruti-
nize“beyond the lumen,”improving characterization of vulnerable
plaque in the carotid arteries and potentially providing a marker
of stroke risk (Wasserman, 2010). A disadvantage of CE-MRA,
however, is that Gadolinium contrast agent administration is con-
traindicated in patients with poor renal function (Morita et al.,
2011).
Perfusion-weighted imaging is similar to CE-MRA in that a
bolus of Gadolinium contrast agent is administered intravenously,
although in this case fast imaging (i.e., EPI or a variant) is
employed to generate a time series of images to track reductions
in T2∗-weighted signal intensity of tissues as the contrast agent
travels through the microvasculature. Semi-quantitative perfusion
maps are obtainable from this examination that estimate cerebral
blood volume (CBV, the blood volume per unit of brain), the mean
transit-time (MTT, the average time required by the bolus of con-
trast agent to cross the capillary network), the cerebral blood flow
(CBF, the volume the blood flowing per brain mass and per unit
of time, mL/100 g tissue/min). When combined with DWI, both
imaging data sets provide information about the ischemic core and
about the ischemic penumbra. It was originally thought that the
difference between the spatial extent of perfusion deficit and DWI
hyperintensity reflected the ischemic penumbra. It is now known
that DWI hyperintensity can resolve in many stroke patients
(Labeyrie et al., 2012), and that the extent of deficits observed
by PWI do not necessarily reflect the true extent of the penumbra.
There is some consensus that penumbra imaging can be used in the
medical decision making, as in the case of rt-PA therapy (Donnan
et al., 2009), however, this imaging approach appears to have gen-
erated mixed results in recent endovascular mechanical embolec-
tomy clinical trials (Tenser et al., 2011; Kidwell et al., 2013).
Lastly, T2∗-weighted imaging has multiple applications in acute
stroke. These applications stem from the fact that the T2∗ of blood
varies with oxygenation content, based on the magnetic suscep-
tibility characteristics of hemoglobin. Oxygenated hemoglobin is
diamagnetic, causing a slight decrease in the applied magnetic field
that is supported within blood, whereas deoxygenated hemoglo-
bin is paramagnetic, concentrating the magnetic field within red
blood cells. Abnormal accumulation of deoxygenated blood thus
provides hypointensity on T2∗-weighted images and is an indica-
tor of vascular pathology. Thus, T2∗-weighted images are capable
of detecting acute hemorrhage, with equivalent accuracy to CT
(Chalela et al., 2007). Microbleeds, indicative of multiple types of
micro-angiopathy are detected on T2∗-weighted images (Fazekas
et al., 1999), but not on CT due to insufficient signal contrast and
spatial resolution. T2∗-weighted images are also capable of depict-
ing hemorrhagic transformations of ischemic infarcts, and provide
indications for ruling out primary hematoma, as well as depicting
thrombosed veins or sinuses. In recent years, T2∗-weighted appli-
cations are being enhanced through use of a technique known
as susceptibility-weighted imaging (SWI; see Figure 1C), which
provides improved characterization of susceptibility changes in
the brain microvasculature for angiography, venography, and
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detection of atherosclerosis and thrombosis (Barnes and Haacke,
2009).
MRI IN STROKE RECOVERY
Despite the continuing technical advances in MRI of acute stroke,
these developments represent only the “tip of the iceberg” with
respect to health care management of all stroke patients. Currently,
only a small fraction of patients are eligible for acute stroke ther-
apy. The remaining stroke survivors are often left with profound
deficits, leading to substantial loss in quality of life, economic
productivity and substantial caregiver burden (Broderick et al.,
1989). In the developed world, the problem is worsening as seniors
become more prevalent due to the “baby boom” generation and
other factors.
Although MRI is often viewed as not widely accessible and
expensive, its versatility and non-invasiveness makes it well suited
for studies involving stroke patients to understand stroke pathol-
ogy and the process of recovery. If useful therapeutic applications
arise from such studies, then MRI could be used potentially as a
biomarker in the clinic. Used sparingly and appropriately, the costs
associated with additional MRI examinations in stroke patients
will be small compared to the costs of caregiving, and any substan-
tial reduction in the extent of disability due to stroke introduced
by such new therapies will be very important. In the remainder of
this review, representative examples are provided that illustrate the
breadth of the opportunity, and also the challenges that lie ahead.
MRI FOR NEUROANATOMICAL CORRELATES OF STROKE
SYMPTOMS
Given the spectrum of deficits exhibited by stroke patients, the
variability in location, and extent of ischemic stroke, and the cur-
rent imperfect understanding of normal brain function in the
young and in the elderly, it is not surprising that there are a substan-
tial number of studies that investigate how stroke lesions in specific
brain locations correlate with behavioral deficit. The use of stroke
patients as a “knock-out” model of brain function can help to clar-
ify the role of a given brain regions, although many strokes are not
sufficiently punctate for definitive conclusions and findings must
be corroborated through replication and consensus. For stroke
patients, improved knowledge of how damaged neuroanatomical
structures relate to behavioral deficits can potentially be important
for refining cognitive and physical rehabilitation strategies, in the
long term.
A simple example illustrating use of MRI in this context involves
use of high resolution T1-weighted images to compare the lesion
location among chronic ambulatory stroke survivors with sym-
metric gait compared to patients with asymmetric gait (Alexander
et al., 2009). Individuals with asymmetric gait were more likely
to have the putamen included in the lesion volume, a structure
essential for motor control (see Figure 4).
Such results are increasingly made possible by new develop-
ments in image processing that facilitate volumetric analysis of
anatomical MRI data. One example is voxel based morphometry
(VBM), an approach that involves spatially registering anatomi-
cal MRI data from a group to a known “atlas” of brain regions,
and then comparing image volumes across brains at each voxel
(Ashburner and Friston, 2000). Another approach is measuring
the cortical thickness by segmenting cortical gray matter from
CSF, and cortical gray matter from subcortical white matter, based
on signal intensity differences in high resolution T1-weighted
images (Fischl and Dale, 2000). Tissue boundaries can then be
represented as convoluted surfaces, with point-to-point thickness
estimates obtained by projecting orthogonally from one surface
to the other. A recent study used VBM to help classify stroke
patients that responded positively to epidural motor cortex stimu-
lation compared to non-responders (Kansagra and Wong, 2008a).
One study of cortical thickness found that patients with severe
cerebrovascular steno-occlusive disease who underwent surgical
revascularization appeared to have replenished the cortex with 5%
increase in thickness (Smith et al., 2010). Some of the challenges
of cortical thickness methods in cerebrovascular patients relate to
the available signal contrast and SNR at 1.5–3.0 Tesla, which may
be addressed by ultra-high field MRI (Zwanenburg et al., 2012).
Furthermore, misclassification of tissue, advanced atrophy, or in
the presence of multiple lesions are additional challenges that may
necessitate within-patient analysis approaches that avoid the image
processing step of group template coregistration (Longstreth et al.,
1998).
DIFFUSION TENSOR IMAGING
It has been known since the 1990s that there is a preferred direc-
tion for water diffusion in certain tissues (i.e., the diffusion is
anisotropic) (Henkelman et al., 1994). The effect is pronounced
in white matter tracts, with diffusion preferentially occurring
along the length of axons, and more restricted in the orthogo-
nal directions. The myelination of axons, the axonal membrane,
and microtubules within axons are all thought to contribute to the
diffusion anisotropy. If a series of DWI scans are conducted with
diffusion weighting in a variety of different orientations, it is pos-
sible to estimate the direction and magnitude of diffusion and the
correlations between diffusion in different directions, properties
that define the anisotropic diffusion tensor and hence lead to the
term “diffusion tensor imaging” (DTI) (Nucifora et al., 2007). A
minimum of 7 DWI experiments with different diffusion orienta-
tions (including one experiment with no diffusion weighting) are
required to calculate diffusion tensor parameters, although encod-
ing for more diffusion directions improves data quality. Thus, DTI
experiments are often time-consuming (approximately 10 min or
longer), even when EPI techniques are used for spatial encoding.
The technique can be sensitive to a variety of different image arti-
facts, including head motion, as the signal attenuation measured in
DWI experiments does not differentiate well between movement
of water molecules on a microscopic or a macroscopic scale.
Data provided by DTI enable calculation of “rotationally invari-
ant” signal contrast parameters that are theoretically independent
of which gradient orientations are chosen for diffusion weighting
(as long as they are well-spaced in 3D). The mean diffusivity para-
meter provides contrast similar to that of the ADC, by providing
a weighted average of diffusion in three orthogonal directions. A
parameter known as the fractional anisotropy (FA) describes the
extent that there is a preferred diffusion direction within a partic-
ular voxel (shown in Figure 3A). The FA value for gray matter is
thus lower than that for white matter, potentially providing a rich
source of information relating to brain connectivity.
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Location of the stroke lesion will strongly influence the poten-
tial for recovery. For example, from lesion analysis work, it is
known that a stroke lesion to the internal capsule is particularly
problematic for motor recovery because the output of motor sig-
nals converges on this subcortical brain structure (Shelton and
Reding, 2001). One of the major appeals of DTI for stroke recov-
ery research is therefore the ability to visualize the integrity of the
corticospinal tract (shown in Figure 3B). DTI can be used to probe
the integrity of the corticospinal tract within the first weeks after
stroke, and early DTI measures are highly correlated with residual
motor function in the acute and chronic stage (Radlinska et al.,
2010). Thus, DTI measures may help to inform whether a patient
has the potential to recover a particular behavior or not.
Diffusion tensor imaging data can also be used for tractogra-
phy, which is a non-invasive method for mapping the paths of
white matter fibers in the brain (Ashburner and Friston, 2000).
Remarkable pictures of white matter tracts have been generated
in monkeys (Adluru et al., 2012) and in the post mortem human
brain (Kansagra and Wong, 2008b) although this image quality
is currently logistically impractical in routine clinical MRI due
to the long scan times that are required. Part of the reason for
these long scan times is that the basic diffusion tensor model
for white matter does not account well for regions of the brain
that have crossing fibers. More sophisticated models require more
gradient orientations, and high spatial resolution is paramount.
This is a promising methodology for use in stroke patients, and
concerted research efforts are under way to improve MRI hard-
ware and enhance the clinical practicality of DTI tractography
(Van Essen et al., 2012). For now, however, FA measures derived
from DTI remain the primary method of quantifying anisotropic
diffusion.
FUNCTIONAL MRI
Blood oxygenation level-dependent (BOLD) fMRI (Ogawa et al.,
1990; Borresen and Lambert, 2008) has revolutionized neuro-
science through its capability to measure signal changes associated
with neuronal activity generated by sensory stimuli, or by behav-
ioral tasks involving memory, cognition, action, or emotion. Neu-
rons communicate with glial cells and the nearby microvasculature
to signal for the delivery of additional blood through vasodilation,
when neuronal activity levels increase. The neurovascular unit that
governs such processes represents the ultimate spatial resolution
achievable with hemodynamic measures of brain activity, in the
range of hundreds of microns (Menon and Goodyear, 1999). Due
to contrast to noise ratio considerations, however, fMRI studies are
typically conducted with voxel dimensions of several millimeters.
Researchers have determined that the local field potentials arising
from healthy populations of neurons are strongly correlated with
BOLD-fMRI signals (Logothetis et al., 2001).
In healthy individuals with an intact neurovascular unit, the
BOLD-fMRI response to neuronal activity is characterized by three
distinct phases: (1) a fast response lasting 1–2 s when there is a
very small decrease in the BOLD signal, (2) a larger hyperemic
signal increase caused by the inflow of oxygenated blood, peaking
approximately 4–5 s after the neural stimulus, and (3) a refractory
period lasting approximately 10 s during which the BOLD signal
undershoots and then reaches the baseline level (Norris, 2006).
FIGURE 3 | Diffusion tensor imaging can be used to visualize the
fractional anisotropy (FA) (A) in white matter (brighter signal means
higher FA) or produce the white matter tracts (B). In this case an atlas
based corticospinal tract is shown in red and overlaid on a coronal
anatomical image. Functional MRI results shows task-based activation (C)
and a resting-state network corresponding to the default mode network (D).
The period of hyperemia provides the most robust means to detect
increases in brain activity and the shape of this hemodynamic
response is often modeled as a gamma-variate function (Cohen,
1997). BOLD signal characteristics are a complex function of mul-
tiple physiological parameters such as CBF, CBV, cerebral rate of
metabolic oxygen consumption, and hematocrit. The key property
used for generating fMRI, through which these other parame-
ter changes are viewed, is the effect of oxygenation status on the
net magnetic susceptibility of blood (oxyhemoglobin is diamag-
netic and deoxyhemoglobin is paramagnetic, as described above).
Thus, the predominant method for measuring BOLD-fMRI signal
changes at 1.5 Tesla and 3.0 Tesla involves using T2∗-weighted EPI
technique to generate time-series data during periods of neuronal
activity. The resulting signal changes are typically small, only a few
percent from signal baseline, partly due to the small volumetric
fraction of blood in tissues. The upper bound for the BOLD sig-
nal, which occurs when deoxyhemoglobin concentrations become
negligible, has been estimated as approximately 6% in gray matter
at 3T (Bulte et al., 2012). Instances where computed BOLD-fMRI
signal changes are larger than 6% should be scrutinized rigorously
for spurious signal contamination, from sources such as larger-
scale vasculature (Nencka and Rowe, 2007) and head motion.
Regarding the latter source of artifact, it is unfortunately the case
that head motions of a few millimeters easily contaminate BOLD-
fMRI signals. This has long been a problem that affects clinical
utility of fMRI, although recent technological improvements are
beginning to have an impact (Rotenberg et al., 2013).
TASK-BASED BOLD FMRI
The majority of the fMRI literature includes task-based
experiments, whereby participants alternate between different
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FIGURE 4 | (A) Overlaid on the average T1-weighted image is a color map showing the average lesion location as a proportion of stroke patients with normal
gait. (B) Among stroke patients with asymmetric gait, there was a higher prevalence of stroke lesion that included the putamen and corona radiata. (Based on
Alexander et al., 2009).
behavioral or stimulus conditions to induce a measurable BOLD
signal change. For example, the simplest approach is to alter-
nate between one specific stimulus/task and a resting condition
(often visual fixation on a displayed cursor). When the stimu-
lus/task is very brief (approximately 0.1–4 s), the experimental
design is described as “event-related,” whereas longer duration
task and control condition periods (typically 15–30 s) are used in
“block-designs” (shown in Figure 3C). In stroke recovery research,
the majority of fMRI studies have used a block-design primar-
ily because the block-design affords greater detection sensitiv-
ity (Calautti and Baron, 2003). Irrespective of the experimental
design, the task of interest is undertaken in multiple repetitions to
improve the ability to detect brain activity under limited SNR con-
ditions. The majority of fMRI analyses use a simple General Linear
Model approach to determine which voxels in the brain show sig-
nal patterns consistent with the task design, while accounting for
the sluggishness of the BOLD hemodynamic response (Price et al.,
2006).
The first task-based fMRI experiment involving stroke patients
dates back to 1997, in which Cramer and colleagues (Cramer et al.,
1997) visualized the brain regions involved when stroke survivors
moved their affected limb. Since this pioneering work, there have
been numerous seminal fMRI studies that have helped to charac-
terize brain activation patterns that indicate positive or negative
outcomes after stroke. For example, one sign of poor recovery
is significant activation in the unaffected hemisphere (i.e., con-
tralateral to the side of the lesion) when performing a unilateral
task with the affected limb. Another is diffuse activation of brain
regions during the execution of a motor task, in regions typically
not observed in healthy individuals performing the same behav-
ior. These observations are supported by a long list of evidence in
the fMRI literature, reviewed by Calautti and Baron (2003) from
cross-sectional and longitudinal fMRI studies.
One of the challenges of task-based fMRI in stroke recovery
research is the issue of task performance. It is important to char-
acterize properly what the patient “does” during fMRI, to rule
out the possibility that their activation patterns are different from
normal individuals simply because they did the task differently
(e.g., speed and extent, applied force, and level of cognitive effort
when performing a motor task). One strategy to circumvent this
important confound for motor fMRI is to measure relevant bio-
physical signals concurrently, such as electromyography (EMG)
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(MacIntosh et al., 2007) or electrodermal activity (EDA) (MacIn-
tosh et al., 2008). EMG provides important information regarding
the timing and intensity of muscle contraction, and potentially the
muscle groups that are activated, if multichannel recordings are
undertaken. EMG may be used to determine if mirror movements
confound the interpretation of brain activation patterns, when
unilateral movement is prescribed. Alternatively, EDA recordings
provide an indirect measure of the autonomic nervous system,
probing aspects of arousal, emotion, and sense of effort. EDA
recordings have been used to characterize sense of effort during
the performance of a motor task with the affected limb post stroke,
as represented in Figure 5.
Despite the wealth of information that can be gained in such
studies, use of task-based BOLD fMRI to study brain activation
in individuals with cerebrovascular disease is not without con-
troversy. Recalling that BOLD signal changes are influenced by
factors such as CBV, CBF, and the cerebral rate of metabolic oxy-
gen consumption, pathological changes in these parameters that
affect fMRI signals may be mistaken for changes in neuronal activ-
ity. For example, a reduction in baseline CBF, due to chronic
hypoperfusion will contribute toward a larger BOLD signal if
neurons remain viable and active in the region. Beyond hemo-
dynamic parameters, medications, and various other stimulants
are known to influence the BOLD-fMRI signal (Pattinson et al.,
2009). It is also possible that the temporal characteristics of the
BOLD response can be affected after stroke, with evidence for this
that dates back a decade (Carusone et al., 2002). Patients with
significant extracranial atherosclerotic stenoses or occlusions may
have a delayed,abnormal BOLD signal response relative to controls
(Donahue et al., 2010), due to potential factors such as collateral
vessels or vascular steal. It may be possible to overcome some of
the limitations of BOLD fMRI in these cases by performing addi-
tional fMRI experiments that rely on non-BOLD contrast, such
as using ASL-based methods for CBF-fMRI (see below) or vas-
cular space occupancy (VASO) CBV-fMRI (Kleim et al., 2002).
This is an area of functional imaging that needs to be devel-
oped if we are to improve our understanding of recovery after
stroke.
Another challenging issue associated with task-based BOLD-
fMRI relates to observances of absent BOLD signals despite
evidence of existing neuronal activity recorded by an alterna-
tive functional neuroimaging modality. Others have found in
stroke that the amplitude of the motor-related BOLD response
is correlated with the capacity of the vessels to dilate, that is
the cerebrovascular reactivity (Krainik et al., 2005). Rossini et al.
(2004) used BOLD fMRI, magnetoencephalography (MEG), and
transcranial doppler (TCD) ultrasound to study chronic stroke
survivors and found that although MEG-evoked responses to
somatosensory stimuli were well detected, an equivalent BOLD
signal was not seen in a subset of patients. In these patients,
the absence of task-related BOLD signal was suggested to arise
from impaired autoregulation of cerebral perfusion, secondary
to cerebrovascular disease. These studies argue for the impor-
tance of understanding the underlying vascular health of patients
when conducting task-related BOLD fMRI, and the need to con-
firm findings through use of multiple functional neuroimaging
modalities.
FIGURE 5 | A task-based fMRI example from a patient with a right side
stroke affecting their right leg. (A) An activation pattern generated using a
standard fMRI model and (B) an activation pattern using an alternative
approach, that is the patient’s electrodermal activity time-series data
measured concurrently. (C) Moving the right affected limb (R:Aff) resulted
in larger and repeated phasic EDA responses compared to the left
unaffected (L:Unaff) limb, where EDA responses are small and habituate.
(D) The event-related fMRI paradigm is shown for reference. These results
suggest moving the affected limb increased arousal and/or effort (Based on
MacIntosh et al., 2008).
RESTING-STATE BOLD FMRI
Resting-state fMRI (rs-fMRI) is a new branch of human brain
mapping that has emerged in recent years (American College of
Sports Medicine et al., 2010), although the seminal work occurred
in 1995 (Jezzard and Balaban, 1995). A major advantage of rs-fMRI
is that it does not require the patient to perform a behavioral task
as part of the examination. Thus, concerns regarding abnormal
behavioral performance of patients are removed. Brain activity
in the resting state is estimated not by task performance, but
by low frequency synchrony in the baseline fMRI signal between
different brain regions, usually in the frequency range between
0.008 and 0.08 Hz. Maps of spatial synchrony can be obtained by
“seed-voxel” approaches, in which the strength of correlations are
reported between the signal from one voxel of interest (e.g., in
primary motor cortex) and the signal from all other voxels; or by
multivariate approaches such as independent component analysis
(ICA) (Beckmann et al., 2005). In either the seed voxel or mul-
tivariate approaches, the resultant large-scale brain networks are
called resting-state networks (RSNs), which are thought to reflect
not anatomical connectivity but instead “functional connectivity”
of the brain (shown in Figure 3D).
Task-based fMRI has been used for stroke recovery research,
while rs-fMRI studies have historically have been less common.
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This trend appears to be changing, particularly as rs-fMRI can
be conducted for patients with profound impairments, rs-fMRI
analysis methods have become more widely available (Filippini
et al., 2009) and test-retest reliability has been established (Ogoh
and Ainslie, 2009). One new phenomenon that would have impli-
cations in stroke rs-fMRI research is how reproducible the signals
are as a function of time, referred to as the temporal stationar-
ity (Willie and Ainslie, 2011). In the future, it may be possible to
find synergies between task and rs-fMRI approaches to advance
our understanding of activation patterns that explain or predict
recovery after stroke.
ARTERIAL SPIN LABELING MRI
Another MRI technique for assessing brain function and physi-
ology is ASL. Although discovered and developed contemporane-
ously, ASL is a complex imaging experiment that historically has
not been used as widely as BOLD fMRI (Williams et al., 1992).
Recent technical advances have made ASL more popular. Two
images are required in ASL; in the first image, RF pulses are used
to invert magnetization in arterial blood proximal to the imaging
region of interest. The “tagged” or “labeled” blood water subse-
quently is allowed to flow into the imaging region for a sufficient
time to reach the microvasculature, causing a small decrease in the
measured MRI signal intensity in proportion to the T1 relaxation
properties of the tagged blood in the microvasculature, and the
microvasculature volume fraction within a given imaging voxel.
The second image (the “control”) has no effective labeling but
otherwise near identical MRI signal contrast weighting. The dif-
ference between the control and tag images provides an image
that is CBF-weighted. Although there are several parameters that
must be measured, or more typically assumed, absolute quantifi-
cation in ASL is relatively straight forward (Wong, 2005; van Osch
et al., 2009). The ASL signal difference (i.e., control – tag images)
divided by the initial magnetization (i.e., related to the proton
density weighting) is directly proportional to perfusion in units of
mL/100 g/min.
As for BOLD fMRI, the ASL perfusion signal is limited by the
small volume fraction of microvascular blood in tissue (1–2%
of the available signal in gray matter). Low SNR is a limitation
of ASL and good temporal image stability is required, as many
images are typically acquired in a time series and then averaged
together to yield a perfusion image. Refinements in MRI hard-
ware and acquisition methods have improved ASL image quality
due to: (1) improved gradient technology for fast imaging; (2)
availability of higher main magnetic field MR systems (e.g., ≥3
Tesla) (Petersen et al., 2010) that lengthen T1 relaxation times and
enhance labeling efficiency; (3) multi-slice capabilities (Gunther
et al., 2005) that improve the volume of coverage; and (4) improved
theoretical models from which quantitative estimates of CBF can
be derived (Chappell et al., 2010).
The ASL technique can be designed to map brain activity anal-
ogous to BOLD signal contrast (Aguirre et al., 2002), or to produce
baseline CBF images (Alsop and Detre, 1996) as an alternative to
PWI, avoiding the use of Gadolinium contrast agents. Two possi-
ble advantages of ASL over BOLD-fMRI are that (1) the ASL signal
is closely associated with CBF, whereas the BOLD signal is of much
more complex signal origins and; (2) the hemodynamic response
of the ASL signal to neuronal activity has improved spatial resolu-
tion. The reduced SNR of ASL images in relation to BOLD-fMRI
images remains a challenge, but the use of ASL to focus on the CBF
characteristics of normal and abnormal cerebrovasculature is very
promising.
The role that ASL can play in imaging acute and chronic stroke
patients remains open for exploration, with the first clinical ASL
stroke study dates back over a decade (Chalela et al., 2000). One
important consideration is the potential use of ASL instead of
PWI, particularly for patients in which Gd-DTPA is contraindi-
cated. Thorough comparisons of the two imaging approaches
are now being conducted in the literature (Siewert et al., 1997;
Weber et al., 2003; Zaharchuk et al., 2009) and in diagnostic imag-
ing departments worldwide, as MRI vendors have recently made
ASL sequences commercially available. PWI and ASL show similar
results in healthy brain tissue, but some divergence has been noted
in cerebrovascular diseases. One option that appears clinically fea-
sible is the inclusion of a 4 to 6-min ASL acquisition to improve the
quantitative accuracy of the PWI-derived CBF maps (Debette and
Markus, 2010). Interestingly, among individuals with suspected
cerebrovascular disease, roughly half of the patients had an abnor-
mal ASL CBF image while the DSC image was viewed as normal
(Zaharchuk et al., 2009).
The ASL method also appears to have an experimental role in
assessing minor stroke or chronic stroke recovery. Specifically, it is
important to identify whether there are delays in the time it takes
the tagged bolus to travel from the labeling plane to the imag-
ing plane. This ASL transit-time metric has an analogous PWI
counterpart, and has been referred to as bolus arrival time, the
arterial arrival time (MacIntosh et al., 2010) and, perhaps most
commonly, the arterial transit-time (ATT or tA) (Wang et al.,
2003). Vascular pathologies and different vascular status can con-
tribute to a delay or hastening of ASL bolus. If unaccounted for,
the delay will manifest as underestimated CBF; decreased ATT will
have the opposite effect. Some clinical ASL studies have incor-
porated ATT estimates, although longer scan durations are often
required. Nonetheless, ATT information may be useful in stroke
diagnosis (Figures 2C,D, patient 2). Future studies should eval-
uate how ATT can be used to improve understanding of stroke
outcomes.
A recent study used ASL to investigate physiological corre-
lates of dementia at 6 years post-stroke, compared to adults with
Alzheimer’s Disease (AD) and healthy controls (Kuller et al., 2004).
In this study structural hippocampal volume was the best predictor
of AD, whereas the ASL was the best predictor of the post-stroke
adults going on to develop dementia. One methodological aspect
of this study was the use of a normalization procedure – the global
gray to white matter CBF ratio – to increase detection sensitivity
as is relatively common in SPECT and PET studies. The normal-
ization of ASL data to provide semi-quantitative images may be
a better alternative to absolute CBF images in clinical scenarios,
in which vastly different resting CBF levels are observed across
patients. Others have shown that use of the normalized CBF image
had higher clinical sensitivity in a study of AD patients when
compared to using the absolute CBF images (Benar et al., 2002).
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FUTURE DIRECTIONS FOR MRI RESEARCH IN STROKE RECOVERY
Given the breadth and versatility of MRI methodology, there are
numerous interesting research directions that can be undertaken
to advance the scientific understanding of stroke recovery, ulti-
mately toward improving health care management of chronic
stroke patients. In this closing section, three MRI approaches are
discussed briefly.
First, similar to the multifaceted acute MRI protocol, the sci-
entific field would benefit from improved integration of multi-
parametric MRI protocols for sub-acute and chronic stroke. For
example, to date there are few examples integrating DTI white
matter tract data, rs-fMRI functional connectivity data, and task-
based fMRI data in stroke patients, yet there should be linkages
between these datasets. It will be important to assess the extent
that each MRI pulse sequence provides unique, clinically rele-
vant information; whether all experiments are required in clinical
research protocols; or whether only the most sensitive indica-
tors are practical for expediency. An additional area requiring
expanded multi-parametric MRI involves improving the quan-
titative interpretation of task-based BOLD-fMRI data. With the
potential to develop MRI experiments sensitive to parameters
such as microvascular CBV and hematocrit, it may be possible
to combine such measures with ASL-derived CBF to model the
relationship between BOLD-fMRI signal changes and cerebral
metabolic rate of oxygen consumption (CMRO2) (Hoge et al.,
1999). The prospect of non-invasive CMRO2 maps would pro-
vide a good marker of neuronal pathology for stroke patients.
Again, the ability to perform such multi-parametric assessments
in a timely fashion remains a challenge. However, this is quite
important given the heterogeneity of MRI findings across stroke
patients, and the wealth of BOLD-fMRI data already collected in
stroke patients that would benefit from more detailed evaluation
and insight. BOLD-fMRI studies in stroke patients also require
additional validation through supplemental measurements using
modalities that do not rely on the neurovascular coupling phe-
nomenon. For assessing cortical activity, electroencephalography
is relatively low-cost and widely available. As in the case of fMRI,
however, electroencephalography datasets are complex and require
careful interpretation.
Second, MRI promises to play a role in the interplay between
genetics and stroke recovery. Recently, a number of fMRI stud-
ies have been undertaken to assess the effects of various genetic
polymorphisms on brain activation patterns. As the role of vari-
ous genetic factors becomes better understood, it is possible that
genetic profile may provide some insight into the potential for
recovery after stroke, and that assists selection of the appropriate
rehabilitation therapy for specific patients (Pearson-Fuhrhop and
Cramer, 2010). For example, polymorphisms of the apolipopro-
tein E (APOE) and brain-derived neurotrophic factor (BDNF)
genes may influence outcome after stroke (Cramer and Procaccio,
2012).
A last area that deserves brief mention is the use of MRI to guide
intervention and rehabilitation. Technology is continually (albeit
slowly) developing toward expanding the list of options for ther-
apeutic intervention for stroke patients in the acute phase. One
example of emerging technology involves use of focused ultra-
sound. Through use of ultrasound transducer arrays with high
channel count, it is becoming possible to distribute heat load
across the skull while adjusting the transmit phase of individ-
ual elements such that they constructively interfere to generate
substantial focused ultrasound pressure fields within the brain
(Clement and Hynynen, 2002). Such systems require detailed mea-
surements of skull thickness (as provided by CT, for example)
to adjust transducer phase appropriately, and MRI guidance to
assess the effects of focused ultrasound treatment. MRI guidance
is critical not only to detect the effects of ultrasound on anatomi-
cal structures, but also because various MRI parameters (and the
Larmor frequency, in particular) are temperature sensitive (Peters
et al., 1998). Thus, specialized MRI techniques provide a method
of non-invasive thermometry that can be used to control focused
ultrasound heat treatments. Completely non-invasive thermal
ablation treatments are possible, as demonstrated in patients with
brain tumors (McDannold et al., 2010), although future applica-
tions to stroke are possible. One such approach involves use of
MRI guided focused ultrasound not for thermal therapy, but for
transient disruption of the blood brain barrier that enables tar-
geted delivery of stem cells for neural repair (Burgess et al., 2011).
Another involves“sonothrombolysis,”in which the combination of
MRI guided focused ultrasound and injected microbubble agents
are potentially used to enhance the ability of tPA to recanalize
vessels (Ricci et al., 2012).
To conclude, MRI is a highly versatile imaging modality that
can be used in numerous different applications to probe the
anatomy and physiology of the healthy and injured brain. Sub-
stantial capacity remains for new technical innovation to expand
the wealth of biophysical information that MRI provides. In the
coming decades, it is very likely that MRI techniques will play a
critical role in the development and subsequent clinical imple-
mentation of new therapeutic strategies to improve outcome after
stroke.
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